P1

////////P2

()

P3

Bottom-up()Top-down()Top-down() (14/54) - - - - (/)(100-103)(101-106) (100-105) (100-103)(100-105)(94-)(98-)(99-103)(99-103) (100-)(98-)(98-102)(99-102) (100-105) (101-105)1.(SI2C)2. ()3.P4

P5

()()98-102()99-102()100-105

P6

98-100-10345

P7

94-1. 2. 3. 4. 5. 98-() 99-103:99-103

P8

101-106100-103100-

P9

()101-()()()

() ()30()P10

1.(NIH)National Institute on Drug Abuse(NIDA), U.S.A.2.National Research Council(NRC), Canada3.JulichForschungszentrum Juelich, Germany4.Interuniversity Micro-Electronics Center(IMEC), Belgium5.The Institute of Physical and Chemical Research(RIKEN), Japan6.National Institute for Materials Science(NIMS), Japan

() () () 1. 2. () () () ()P11 ()

////////P12

97-101P13()

Chart1

1054115441.8758

1127115442.0462.7

1057113440.5362.9

872107037.7860.1

1056109544.3458.22

()

1

()

971,0541,15441.8758.00

981,1271,15442.0462.70

991,0571,13440.5362.90

1008721,07037.7860.10

1011,0561,09544.3458.22

1,147346

1,240365

1,513448

2,811755

3,350981

979899100101

31212861297731033546

739655677761779

38603516365438644325

12891162118811371558

327316293323360

16161478148114601918

41.865284974142.036405005740.530925013737.78467908944.3468208092

101 ()P14

Chart1

2139946.5

59027446.4

186380042.9

88038543.8

1

2139946.50

59027446.40

1,86380042.90

88038543.80

979899100101

31212861297731033546

739655677761779

38603516365438644325

12891162118811371558

327316293323360

16161478148114601918

41.865284974142.036405005740.530925013737.78467908944.3468208092

101 ()P15

()123213561429946.543.41,1725901491011527446.445.61,0961,86340911427780042.948.91,0098802012915538543.847.81,129 3,5468151545891,55843.947.71,064

101 ()P16

Chart1

603151.7

1225242.6

40518445.4

1929348.4

1

603151.70

1225242.60

40518445.40

1929348.40

979899100101

31212861297731033546

739655677761779

38603516365438644325

12891162118811371558

327316293323360

16161478148114601918

41.865284974142.036405005740.530925013737.78467908944.3468208092

101 ()P17

()12360190123151.738.71,082122321195242.638.51,010405114244618445.438.0914192505389348.446.21,209 7792153011536046.240.31,018

99-101 P18

993312117100974040171013415151110229

P1999-101

99113311007111101400099000010010432101411099127741002866310117553

////////P20

P21

1-122-83-1249123()511293266812()7-1~28(/)-1~26~79(/)-1~26~79~1010()()

P22

1-101.10.122101.09.28102.01.313101.9.30102.01.284(NRPB)100.10.15101.12.30()5101.11.15102.03.016-

P23

(AB)()(A)A(RPI)(B)--(5)--

1.2. SCISSCIEI()(2008.1.1) P24

SCISSCIEI (()1.) (3)SCISSCIEI ()()

()() P25

()1. 97 (97.1.1~97.12.31)2. 98 (98.1.1~98.12.31)3. 99 (99.1.1~99.12.31)4. 100(100.1.1~100.12.31)5. 101(101.1.1~)

(51.( * ) P I () Impact Factor2. Ranking / Category 60 66/603. 4. JCR P26

Chiu JJ, Chien S. Effects of disturbed flow on vascular endothelium : Pathophysiological basis and clinical perspectives. Physiol Rev. 2011,91:1-61. ( I F=26.866R/C= 1/79PHYSIOLOGY )Cover xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxTsai MC, Chen L, Zhou J, Tang Z, Hsu TF, Wang Y, Shih YT, Peng HH, Wang N, Guan Y, Chien S, Chiu JJ*. Shear stress induces synthetic-to-contractile phenotypic modulation in smooth muscle cells via peroxisome proliferator-activated receptor alpha/delta activations by prostacyclin released by sheared endothelial cells. Circ Res. 2009,105: 471-80. ( I F=9.489R/C= 4/117CARDIAC & CARDIOVASCULAR SYSTEMS )Xxxxxxxxxx xxxxxxxxxxxxxxxxx

()1.2. P27

12

/()//

(70)(70-63) (62-57) (56-50) (< 50) _________1.2.3.4.5. (30) (30-27) (26-23) (22-20) (< 20) _________1.2. _________________ () (A)( 90) (B)(89- 80) (C)(79-70) (D)(< 70) ? P28

95-101 ( )P29

Chart1

6.294182962.010895261147346883285

6.963861642.159547381240365983300

8.531553312.6001399715134481221364

15.616344894.5494854628117552275634

17.834872525.1694116833509812536711

15.744.62341511372254664

16.414.8728919122077627

1

956.292.011,147346883285

966.962.161,240365983300

978.532.601,5134481,221364

9815.624.552,8117552,275634

9917.835.173,3509812,536711

10015.744.623,4151,1372254664

10116.414.872,8919122077627

1,147346

1,240365

1,513448

2,811755

3,350981

95-101 :1011025P30

959697981,1473461,2403651,5134482,8117558832859833001,2213642,275634(%)77.082.479.382.280.781.380.984.0()6.292.016.962.168.532.6015.624.55

991001011023,3509813,4151,1372,9239172,5367112,2546642,133654(%)75.772.566.058.473.071.3()17.835.1715.744.6216.414.87

20%20% 1. (1) 3(2009/1/1~)40% SCI (2) 5(2007/1/1~)20% SCI (3) 3(2009/1/1~)2. (1) 3(2009/1/1~)10% SCI(2) 3(2009/1/1~) 22 4 0P31PI ()

RPI//////////P32

RPI (Research Performance Index)(Impact Factor, IF)SCI/SSCI/A&HCI/EIP33

RPI (Research Performance Index) IFRPI RPI P34

RPI 1. RPI IFSCI)2. impact factorP35

SOP

P36

() P37

(1) (2)P38++++

21123122

- - 1~6()P39

:1. 2. P40

97041117980111369939002141007801117102223744

:996210990042604P41

1A98C012B12ABC3973 13ABCD496A44 4A9451RPI 1

5A951

50% 13 P42

P43

()()1 5. (2%25)501.2.3.()

////////P44

P45

P46

Q & AP47

P2099-101

991266410010663101125529910001001000101322299722110031101014110991888310060001016222

(1) (1W/2923) (2)P35++++

21123122

*********